70%Confidence
0Views
FDASource
2026-04-08Date
Summary
Radnostix's Class III recall for failed capsule specifications in a diagnostic kit suggests minor quality issues with limited immediate health risks. This is the least serious recall class but still indicates manufacturing process deviations that need correction.
Actionable: Monitor for any follow-up regulatory communications but consider this a low-impact event for the broader market.
AI Confidence: 70%
Data Points
firmRadnostix
classificationClass III
statusOngoing
distributionNationwide in the US, including Puerto Rico
productGelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, Internation
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now